The Ulysses Strategy
“The Ulysses Strategy” – The New Yorker
“The Ulysses Strategy” – The New Yorker
“Beyond Comprehension”
There’s plenty of price gouging in American healthcare. The pharmaceutical industry has gotten plenty of (well deserved) bad press for its pricing practices. At the extreme are people like “Pharma Bro” (and convicted felon) Martin Shkreli, who hiked the price of an important medication to treat infections in AIDS patients by over 5000%. But high and…
The Commonwealth Fund recently circulated information on the widespread difficulty many Americans have paying for their medical care, even when they have insurance. Burdened by high co-pays and high coinsurance rates, these out-of-pocket expenses are putting people on the financial edge. Here is a picture of the results, which show that a third of people…
In a previous post, I argued in favor of Rob Califf as FDA Commissioner. Here is an article from the Duke Chronicle, exploring more of this important debate. Dr. Robert Califf, former vice chancellor of clinical and translational research, may soon be taking helm of the U.S. Food and Drug Administration, but not without resistance from organizations…
I recognize that correlation does not prove causation. But here is a picture illustrating the correlation between income inequality and the percent of a country’s population that is obese. The findings are provocative, to say the least. Making the relationship somewhat plausible is all the evidence we have now of the toll that income inequality…
I post pretty regularly on out-of-pocket medical expenses, a topic I’ve been conducting research on, and one that will fit centrally into the new book I’m writing. Most often when people think about paying for medical care, they think about medications. But as this figure from the Kaiser Family Foundation shows, don’t forget about the…